OMX Nordic 40
2.437,72
PKT
+25,37
PKT
+1,05
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 11.01.18 | Volvo (B) Underweight | Morgan Stanley | |
| 11.01.18 | ABB (Asea Brown Boveri) Neutral | Citigroup Corp. | |
| 11.01.18 | AstraZeneca buy | Deutsche Bank AG | |
| 10.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 09.01.18 | ABB (Asea Brown Boveri) Hold | Société Générale Group S.A. (SG) | |
| 09.01.18 | Volvo (B) Hold | Société Générale Group S.A. (SG) | |
| 09.01.18 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 09.01.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.01.18 | ABB (Asea Brown Boveri) Neutral | Merrill Lynch & Co., Inc. | |
| 08.01.18 | Novo Nordisk buy | UBS AG | |
| 08.01.18 | AstraZeneca Neutral | UBS AG | |
| 08.01.18 | Nokia overweight | JP Morgan Chase & Co. | |
| 05.01.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.01.18 | Nokia Neutral | Credit Suisse Group | |
| 05.01.18 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 04.01.18 | Nokia Strong Buy | S&P Capital IQ | |
| 03.01.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 29.12.17 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.12.17 | Novo Nordisk Verkaufen | DZ BANK | |
| 14.12.17 | ABB (Asea Brown Boveri) kaufen | Kepler Cheuvreux | |
| 12.12.17 | Nokia overweight | JP Morgan Chase & Co. | |
| 12.12.17 | Novo Nordisk buy | UBS AG | |
| 12.12.17 | Volvo (B) Neutral | UBS AG | |
| 12.12.17 | ABB (Asea Brown Boveri) Sell | UBS AG | |
| 11.12.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.12.17 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 07.12.17 | Novo Nordisk Reduce | HSBC | |
| 06.12.17 | Novo Nordisk overweight | Morgan Stanley | |
| 06.12.17 | Novo Nordisk buy | UBS AG | |
| 06.12.17 | Novo Nordisk buy | Deutsche Bank AG | |
| 06.12.17 | Fortum Sell | Deutsche Bank AG | |
| 06.12.17 | Novo Nordisk buy | Merrill Lynch & Co., Inc. | |
| 06.12.17 | Novo Nordisk Underweight | JP Morgan Chase & Co. | |
| 06.12.17 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 05.12.17 | AstraZeneca buy | Deutsche Bank AG | |
| 04.12.17 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 02.12.17 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 01.12.17 | AstraZeneca Equal-Weight | Morgan Stanley |